Overview
- The proposed settlement requires the sale of 164 home health and hospice locations in 19 states, representing about $528 million in annual revenue.
- Amedisys will pay a $1.1 million civil penalty for falsely certifying its Hart-Scott-Rodino Act filings.
- A court-appointed monitor will oversee divestiture compliance and can mandate eight additional facility sales if initial approvals fail.
- Assets will be transferred to BrightSpring Health Services and The Pennant Group to maintain competition in overlap markets.
- The consent decree and competitive impact statement will appear in the Federal Register for a 60-day Tunney Act comment period before final judicial approval.